Cargando…

Objective measurement in Parkinson’s disease: a descriptive analysis of Parkinson’s symptom scores from a large population of patients across the world using the Personal KinetiGraph®

BACKGROUND: The Personal KinetiGraph® (PKG®) Movement Recording System provides continuous, objective, ambulatory movement data during routine daily activities and provides information on medication compliance, motor fluctuations, immobility, and tremor for patients with Parkinson’s disease (PD). Re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pahwa, Rajesh, Bergquist, Filip, Horne, Malcolm, Minshall, Michael E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193385/ https://www.ncbi.nlm.nih.gov/pubmed/32377368 http://dx.doi.org/10.1186/s40734-020-00087-6

Ejemplares similares

Comparing Objective and Subjective Measures of Parkinson's Disease Using the Parkinson's KinetiGraph
por: Knudson, Mei, et al.
Publicado: (2020)

The Use of Data from the Parkinson’s KinetiGraph to Identify Potential Candidates for Device Assisted Therapies
por: Khodakarami, Hamid, et al.
Publicado: (2019)

Identification and quantitative assessment of motor complications in Parkinson’s disease using the Parkinson’s KinetiGraph™
por: Qu, Yan, et al.
Publicado: (2023)

More Sensitive Identification for Bradykinesia Compared to Tremors in Parkinson’s Disease Based on Parkinson’s KinetiGraph (PKG)
por: Chen, Lina, et al.
Publicado: (2020)

Qualitative Evaluation of the Personal KinetiGraph(TM) Movement Recording System in a Parkinson’s Clinic
por: Santiago, Anthony, et al.
Publicado: (2019)

Introducing the Parkinson’s KinetiGraph into Routine Parkinson’s Disease Care: A 3-Year Single Centre Experience
por: Dominey, Thea, et al.
Publicado: (2020)

Does Information from the Parkinson KinetiGraph™ (PKG) Influence the Neurologist’s Treatment Decisions?—An Observational Study in Routine Clinical Care of People with Parkinson’s Disease
por: Sundgren, Mathias, et al.
Publicado: (2021)

An Objective Fluctuation Score for Parkinson's Disease
por: Horne, Malcolm K., et al.
Publicado: (2015)

Clinical correlates of movement disorders in adult Niemann-Pick type C patients measured via a Personal KinetiGraph
por: El-Masri, Shaddy, et al.
Publicado: (2022)

Parkinson’s Kinetigraph in the Selection of Levodopa-Carbidopa Intestinal Gel for Motor Fluctuations Refractory to Deep Brain Stimulation
por: Noui, Yassine, et al.
Publicado: (2021)

Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease
por: Odin, Per, et al.
Publicado: (2018)

A blinded, controlled trial of objective measurement in Parkinson’s disease
por: Woodrow, Holly, et al.
Publicado: (2020)

Optimizing Treatment of Parkinson’s Disease
por: Nyholm, Dag, et al.
Publicado: (2022)

Automatic Spiral Analysis for Objective Assessment of Motor Symptoms in Parkinson’s Disease
por: Memedi, Mevludin, et al.
Publicado: (2015)

Objective measurement in routine care of people with Parkinson’s disease improves outcomes
por: Farzanehfar, Parisa, et al.
Publicado: (2018)

Innovations in Thermal Processing: Hot-Melt Extrusion and KinetiSol® Dispersing
por: Tan, Deck Khong, et al.
Publicado: (2020)

Improved Dissolution and Pharmacokinetics of Abiraterone through KinetiSol(®) Enabled Amorphous Solid Dispersions
por: Gala, Urvi, et al.
Publicado: (2020)

A review of ropinirole prolonged release in Parkinson’s disease
por: Nashatizadeh, Muhammad M, et al.
Publicado: (2009)

Prediction of the Levodopa Challenge Test in Parkinson’s Disease Using Data from a Wrist-Worn Sensor
por: Khodakarami, Hamid, et al.
Publicado: (2019)

Sensor Measurements Can Characterize Fluctuations and Wearing Off in Parkinson’s Disease and Guide Therapy to Improve Motor, Non-motor and Quality of Life Scores
por: Farzanehfar, Parisa, et al.
Publicado: (2022)

Evaluation of morning bradykinesia in Parkinson’s disease in a United States cohort using continuous objective monitoring
por: Isaacson, S.H., et al.
Publicado: (2022)

Pupillary Response to Postural Demand in Parkinson’s Disease
por: Kahya, Melike, et al.
Publicado: (2021)

Amantadine extended-release capsules for levodopa-induced dyskinesia in patients with Parkinson’s disease
por: Sharma, Vibhash D, et al.
Publicado: (2018)

Istradefylline for OFF Episodes in Parkinson’s Disease: A US Perspective of Common Clinical Scenarios
por: Isaacson, Stuart H, et al.
Publicado: (2022)

Predictors of Mild Cognitive Impairment in Early-Stage Parkinson's Disease
por: Hanna-Pladdy, Brenda, et al.
Publicado: (2013)

Should “on-demand” treatments for Parkinson’s disease OFF episodes be used earlier?
por: Isaacson, Stuart H., et al.
Publicado: (2022)

Clinical Use of On-Demand Therapies for Patients with Parkinson’s Disease and OFF Periods
por: Pahwa, Rajesh, et al.
Publicado: (2023)

Graph Theory on Brain Cortical Sources in Parkinson’s Disease: The Analysis of ‘Small World’ Organization from EEG
por: Vecchio, Fabrizio, et al.
Publicado: (2021)

Graph Neural Networks for Parkinson’s Disease Monitoring and Alerting
por: Zafeiropoulos, Nikolaos, et al.
Publicado: (2023)

Khodakarami, H., et al., Prediction of the Levodopa Challenge Test in Parkinson’s Disease Using Data from a Wrist-Worn Sensor. Sensors 2019, 19, 5153
por: Khodakarami, Hamid, et al.
Publicado: (2020)

Pupillary Response to Cognitive Demand in Parkinson’s Disease: A Pilot Study
por: Kahya, Melike, et al.
Publicado: (2018)

Application of single wrist-wearable accelerometry for objective motor diary assessment in fluctuating Parkinson’s disease
por: Löhle, Matthias, et al.
Publicado: (2023)

At-Home Blood Pressure Measurements Provide Better Assessments of Orthostatic Hypotension in Parkinson’s Disease
por: Fernando, Chathurini V, et al.
Publicado: (2023)

Haptic Perception of Object Curvature in Parkinson's Disease
por: Konczak, Jürgen, et al.
Publicado: (2008)

Graph Theoretical Analysis of Semantic Fluency in Patients with Parkinson's Disease
por: Zhang, Guanyu, et al.
Publicado: (2022)

A method for measuring time spent in bradykinesia and dyskinesia in people with Parkinson’s disease using an ambulatory monitor
por: Khodakarami, Hamid, et al.
Publicado: (2021)

Screening, Diagnosis, and Management of Parkinson’s Disease Psychosis: Recommendations From an Expert Panel
por: Pahwa, Rajesh, et al.
Publicado: (2022)

Pulmonary Safety and Tolerability of Inhaled Levodopa (CVT-301) Administered to Patients with Parkinson's Disease
por: LeWitt, Peter A., et al.
Publicado: (2018)

Accuracy of Step Count Estimations in Parkinson’s Disease Can Be Predicted Using Ambulatory Monitoring
por: Shokouhi, Navid, et al.
Publicado: (2022)

Correction to: Screening, Diagnosis, and Management of Parkinson’s Disease Psychosis: Recommendations From an Expert Panel
por: Pahwa, Rajesh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4t2ofimv40nn7pmpcpedgi8r3a